These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 16310587)

  • 61. [Methylphenidate double-blind trial: indication and performing].
    Bliznakova L; Gerstner S; Schmidt MH; Becker K
    Klin Padiatr; 2007; 219(1):9-16. PubMed ID: 17205427
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Case of a 67-year-old woman diagnosed with ADHD successfully treated with methylphenidate.
    da Silva MA; Louza M
    J Atten Disord; 2008 May; 11(6):623. PubMed ID: 18417727
    [No Abstract]   [Full Text] [Related]  

  • 63. Insomnia, night terror, and depression related to clonidine in attention-deficit/hyperactivity disorder.
    Ghanizadeh A
    J Clin Psychopharmacol; 2008 Dec; 28(6):725-6. PubMed ID: 19011458
    [No Abstract]   [Full Text] [Related]  

  • 64. [The costs of drugs against ADDH should be reduced].
    Rise L
    Lakartidningen; 2003 Jun; 100(26-27):2316; author reply 2316. PubMed ID: 12872384
    [No Abstract]   [Full Text] [Related]  

  • 65. Visual function and ocular features in children and adolescents with attention deficit hyperactivity disorder, with and without treatment with stimulants.
    Grönlund MA; Aring E; Landgren M; Hellström A
    Eye (Lond); 2007 Apr; 21(4):494-502. PubMed ID: 16518370
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Pharmacotherapy of attention-deficit hyperactivity disorder in children and adolescents: update on new stimulant preparations, atomoxetine, and novel treatments.
    Prince JB
    Child Adolesc Psychiatr Clin N Am; 2006 Jan; 15(1):13-50. PubMed ID: 16321724
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Attention-deficit/hyperactivity disorder: using P300 topography to choose optimal treatment.
    Sangal RB; Sangal JM
    Expert Rev Neurother; 2006 Oct; 6(10):1429-37. PubMed ID: 17078784
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Acute effects of methylphenidate on performance during the Test of Variables of Attention in children with attention deficit/hyperactivity disorder.
    Huang YS; Chao CC; Wu YY; Chen YY; Chen CK
    Psychiatry Clin Neurosci; 2007 Jun; 61(3):219-25. PubMed ID: 17472588
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The parent's perspective.
    Colley M
    Arch Dis Child; 2005 Feb; 90 Suppl 1(Suppl 1):i8-9. PubMed ID: 15665155
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Paying attention. The controversy over ADHD and the drug Ritalin is obscuring a real look at the disorder and its underpinnings.
    Leutwyler K
    Sci Am; 1996 Aug; 275(2):12; 14. PubMed ID: 8693319
    [No Abstract]   [Full Text] [Related]  

  • 71. Thinking differently. Brain scans give new hope for diagnosing ADHD.
    Rogers A
    Newsweek; 1998 Dec; 132(23):60. PubMed ID: 10345222
    [No Abstract]   [Full Text] [Related]  

  • 72. Perceived passage of time: its possible relationship to attention-deficit hyperactivity disorder.
    Goddard J
    Med Hypotheses; 2000 Oct; 55(4):351-2. PubMed ID: 11000066
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Effectiveness of methylphenidate in the treatment of encopresis whether or not attention-deficit/hyperactivity disorder symptoms are present.
    Yilmaz S; Akça OF
    J Child Adolesc Psychopharmacol; 2013 Nov; 23(9):632-3. PubMed ID: 24251646
    [No Abstract]   [Full Text] [Related]  

  • 74. Recent developments in direct consumer advertising of attention disorder stimulants and creating limits to withstand constitutional scrutiny.
    Strawn MN
    J Contemp Health Law Policy; 2003; 19(2):495-520. PubMed ID: 14748255
    [No Abstract]   [Full Text] [Related]  

  • 75. [EEG diagnosis before beginning and during drug treatment of hyperkinetic children and adolescents].
    Gabriel KH
    Z Kinder Jugendpsychiatr Psychother; 2003 Aug; 31(3):231-2; author reply 233-4. PubMed ID: 12942795
    [No Abstract]   [Full Text] [Related]  

  • 76. Mechanism of action of stimulants in attention-deficit/hyperactivity disorder.
    Stahl SM
    J Clin Psychiatry; 2010 Jan; 71(1):12-3. PubMed ID: 20129003
    [No Abstract]   [Full Text] [Related]  

  • 77. [Treatment with central nervous system stimulants].
    Zlotnik G
    Ugeskr Laeger; 2004 Mar; 166(10):925; author reply 925. PubMed ID: 15045741
    [No Abstract]   [Full Text] [Related]  

  • 78. Attention-Deficit Hyperactivity Disorder.
    DuPont RL
    Essent Psychopharmacol; 2005; 6(5):iv. PubMed ID: 16222908
    [No Abstract]   [Full Text] [Related]  

  • 79. Effect of nootropic and psycho-stimulants on children with infantile brain damages.
    Vehreschild T
    Acta Paedopsychiatr; 1990; 53(2):163-7. PubMed ID: 1980990
    [No Abstract]   [Full Text] [Related]  

  • 80. New approaches to the management and treatment of attention-deficit/hyperactivity disorder.
    Am J Manag Care; 2004 Jul; 10(4 Suppl):S87-8. PubMed ID: 15352534
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.